Management of ankylosing spondylitis

  • Joachim Sieper
  • Jürgen Braun


Recently, the Assessment of SpondyloArthritis international Society (ASAS) and European League Against Rheumatism (EULAR) recommendations on the management of AS have been published, based on a thorough analysis of the available literature and on a meeting of spondyloarthritides (SpA) experts. These recommendations are shown in Figures 6.1 and 6.2 [54]. Non–drug approaches are part of the therapy at all stages of the disease. For the predominantly axial manifestation, the treatment options are limited to non–steroidal anti–inflammatory drugs (NSAIDs) as a kind of basic treatment, followed by tumour necrosis factor (TNF)–blocker therapy if this conventional treatment fails. If the clinical picture is dominated by peripheral symptoms such as arthritis or enthesitis, treatment with sulfasalazine and/or local steroid injection should be tried first before TNF blockers are considered.


Ankylose Spondylitis Numerical Rating Scale Bath Ankylose Spondylitis Disease Activity Index Bath Ankylose Spondylitis Functional Index Bath Ankylose Spondylitis Metrology Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Joachim Sieper
    • 1
  • Jürgen Braun
    • 2
  1. 1.Charité University HospitalBerlinGermany
  2. 2.Rheumatology Center RuhrgebietHerneGermany

Personalised recommendations